首页> 外国专利> Producing 1,4-diphenylazetidinone derivatives useful as cholesterol resorption inhibitors from protected beta-substituted amino amides comprises using a quaternary phosphonium salt catalyst

Producing 1,4-diphenylazetidinone derivatives useful as cholesterol resorption inhibitors from protected beta-substituted amino amides comprises using a quaternary phosphonium salt catalyst

机译:由受保护的β-取代的氨基酰胺生产可用作胆固醇吸收抑制剂的1,4-二苯基氮杂环丁酮衍生物包括使用季phospho盐催化剂

摘要

Producing 1,4-diphenylazetidinone derivatives from protected beta -substituted amino amides in the presence of a silylating agent and a cyclization catalyst comprises using a catalyst comprising quaternary phosphonium cation and an organonitrogen anion or an alcoholate or carboxylate anion or a chloride, bromide or iodide anion in combination with silver(I) oxide. Producing 1,4-diphenylazetidinone derivatives from protected beta -substituted amino amides in the presence of a silylating agent and a cyclization catalyst comprises using a catalyst comprisi ng quaternary phosphonium cation of formula P +R 16R 17R 18R 19 (XII) and an organonitrogen anion of formula (VIII)-(XI or an alcoholate anion R 41O - or carboxylate anion R 42COO - or a chloride, bromide or iodide anion in combination with silver(I) oxide. R 16-R 19aryl, 1-15C alkyl or benzyl; Z : CO, CS, SO, SO 2 or C=NR 20; K : O, S, NR 21 or CR 22R 23; L : NR 24 or CR 25R 26; n : 0 or 1; M : O, CO, NR 27 or CR 28R 29; Q : O, S, NR 30, CR 31R 32, CO, CS, SO, SO 2 or C=NR 34; R : CR 35 or N; T : CR 36 or N; U : CR 37 or N; V : CR 38 or N; R 20-R 32, R 34-R 38H, 1-6C alkyl, aryl or heteroaryl, where pairs of alkyl groups can form 3-6C cycloalkylene groups optionally substituted with halo, CF 3, NO 2, COOR, CONRR, cycloalkyl, 1-10C alkyl, 2-6C alkenyl, OR, OCOR, O-CO-(1-6C)alkylene-Ar, SO 2NRR, SR, SR', SOR, SOR', SO 2R, SO 2R', SO 2NRR' or SO 2NR'R' or with NRR, NHCONHR, NHCONHAr', NRCOR, NRCOOR, NRCOAr', NRCOOAr', NRCONRR, NRCON(R)Ar', NRCONAr'Ar', NAr'COR, NAr'COOR, NAr'COAr', NAr'COOAr', NAr'CONRR, NAr'CON(R)Ar', NAr'CONAr'Ar', Ar' or O(CH 2) nAr'; R : 1-6C alkyl; R' : (CH 2) nAr; n : 0-6; Ar : aryl optionally substituted with 1-2 of F, Cl, Br, CF 3, SF 5, NO 2, OCF 3, OR or R; Ar' : aryl optionally substituted with 1-3 of halo, CF 3, NO 2, OCF 3, OR, R, NRR, SF 5, SO 2Me or COOR; R 39, R 401-6C alkyl in which nonadjacent C atoms can be replaced by NH or CO, 1-6C perfluoroalkyl, aryl or heteroaryl, or R 39+R 40 = 1,8-naphthyl or 1,7,7-trimethylbicyclo[2.2.1]heptanyl, or R 40 = H; R 41aryl, 1-14C alkyl or benzyl; R 421-15C alkyl, benzyl, 5-8C cycloalkyl, or aryl optionally substituted with halo, OH, OR", NH 2, NHR", NR"R", COOH, COOR", CONH 2, CONHR", CONR"R", SO 2NH 2, SO 2NHR", SO 2NR"R", CN, 1-12C alkyl or 5-8C cycloalkyl; R" : 1-3C alkyl. [Image] ACTIVITY : Antilipemic; Antiarteriosclerotic. MECHANISM OF ACTION : Cholesterol resorption inhibitor.
机译:在甲硅烷基化剂和环化催化剂的存在下,由受保护的β-取代的氨基酰胺生产1,4-二苯基氮杂环丁酮衍生物,包括使用包含季and阳离子和有机氮阴离子或醇或羧酸根阴离子或氯,溴或碘的催化剂。阴离子与氧化银(I)结合使用。在甲硅烷基化剂和环化催化剂的存在下,由受保护的β-取代的氨基酰胺生产1,4-二苯基氮杂环丁酮衍生物包括使用包含式P +> R 16> R 17> R 18> R 19的季phospho阳离子的催化剂>(XII)和式(VIII)-(XI的有机氮阴离子)或醇根阴离子R 41> O->或羧酸根阴离子R 42> COO->或氯化物,溴化物或碘化物阴离子与银(I)组合R 16> -R 19>芳基,1-15C烷基或苄基; Z:CO,CS,SO,SO 2或C = NR 20; K:O,S,NR 21或CR 22> R 23。 >; L:NR 24>或CR 25> R 26>; n:0或1; M:O,CO,NR 27>或CR 28> R 29>; Q:O,S,NR 30>,CR 31 > R 32>,CO,CS,SO,SO 2或C = NR 34>; R:CR 35>或N; T:CR 36>或N; U:CR 37>或N; V:CR 38>或N; R 20> -R 32>,R 34> -R 38> H,1-6C烷基,芳基或杂芳基,其中烷基对可以形成3-6C环亚烷基,任选地被卤素,CF 3,NO 2取代,COOR,CONRR,环烷基,1-10C烷基,2-6C烯基,或,OCOR,O -CO-(1-6C)亚烷基-Ar,SO 2NRR,SR,SR',SOR,SOR',SO 2R,SO 2R',SO 2NRR'或SO 2NR'R'或带有NRR,NHCONHR,NHCONHAr' NRCOR,NRCOOR,NRCOAr',NRCOOAr',NRCONRR,NRCON(R)Ar',NRCONAr'Ar',NAr'COR,NAr'COOR,NAr'COAr',NAr'COOAr',NAr'CONRR,NAr'CON( R)Ar',NAr'CONAr'Ar',Ar'或O(CH 2)nAr'; R:1-6C烷基; R':( CH 2)nAr; n:0-6; Ar:任选地被F,Cl,Br,CF 3,SF 5,NO 2,OCF 3,OR或R中的1-2个取代的芳基; Ar':任选被1-3个卤素,CF 3,NO 2,OCF 3,OR,R,NRR,SF 5,SO 2Me或COOR取代的芳基; R 39>,R 40> 1-6C烷基,其中不相邻的C原子可被NH或CO取代,1-6C全氟烷基,芳基或杂芳基,或R 39> + R 40> = 1,8-萘基或1, 7,7-三甲基双环[2.2.1]庚基,或R 40> = H; R 41>芳基,1-14C烷基或苄基; R 42> 1-15C烷基,苄基,5-8C环烷基或任选地被卤素,OH,OR”,NH 2,NHR”,NR” R”,COOH,COOR”,CONH 2,CONHR”,CONR取代的芳基“ R”,SO 2 NH 2,SO 2NHR”,SO 2NR“ R”,CN,1-12C烷基或5-8C环烷基; R”:1-3 C烷基。活动:抗血脂;抗动脉硬化。作用机理:胆固醇吸收抑制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号